baber/WOPTO huggingface dataset:
Patent CA-2209528-A1 (CA)
Title: Method and system for automatic activation of a wireless device
Inventor: LIPSIT JAMES MASON
IPC: G06F21/00
Filed: 1997-07-03
Abstract: Methods and apparatus for automatic activation of a wireless device in a sub scription activation system are provided which use information received from a program med but non-activated device. In one variation, the subscription activation system d etermines that the received information satisfies a parameter necessary for activation. In another varia tion, the subscription activation system verifies that the information received satisfies a previou sly determined criterion necessary for activation. Based upon the above, the subscription activation system activates the device. In a related manner, a system is constructed which uses an activatio n unit configured to receive and process information from a programmed non-activated wireless dev ice. Using the information, the activation unit determines if activation criteria necessary  for activation of the programmed wireless device in the system are satisfied and, based upon the i nformation and if the criteria are satisfied, the activation unit activates the wireless device in  the system.
Patent CA-2209858-A1 (CA)
Title: Il-2r-associated polypeptide and dna molecules coding therefor
Inventor: BARSOUMIAN EDWARD LEON
IPC: C12N5/10
Filed: 1995-12-23
Abstract: The present invention relates to a polypeptide, p43, which is associated with the interleukin-2 receptor (IL-2R). It binds specifically to the .beta. and .gamma. subunits of IL-2R and is further capable of binding NAD+. The invention is further related to nucleic acid molecules coding for p43 and to antibodies specifically binding p43.
Patent CA-2212731-A1 (CA)
Title: Compositions and methods for the treatment and diagnosis of cardiovascular disease
Inventor: FALB DEAN A
IPC: A61K48/00
Filed: 1996-02-09
Abstract: The present invention relates to methods and compositions for the treatment and diagnosis of cardiovascular disease, including, but not limited to, atherosclerosis, ischemia/reperfusion, hypertension, restonesis, and arterial inflammation. Specifically, the present invention identifies and describes genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.  Further, the present invention identifies and describes genes via the ability of their gene products to interact with gene products involved in cardiovascular disease. Still further, the present invention provides methods for the identification and therapeutic use of compounds as treatments of cardiovascular disease. Moreover, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of cardiovascular disease, and for monitoring the efficacy of compounds in clinical trials. Additionally, the present invention describes methods for the diagnostic evaluation and prognosis of various cardiovascular diseases, and for the identification of subjects exhibiting a predisposition to such conditions.
Patent CA-2212762-A1 (CA)
Title: Programmable radio subscription system for receiving selectively defined information
Inventor: GOLDMAN SHELLEY B
IPC: H04B1/06
Filed: 1997-08-12
Abstract: The radio subscription system of the present invention enables a subscriber to remotely define and identify one or more playlists, each specifying information content selected by the subscriber from a subscription content database, for later transmission to the subscriber's radio. The radio subscription system also permits the subscriber to use the local subscriber radio to remotely request transmission of a particular playlist to the subscriber's radio for storage and playback. The subscriber may then use the local subscriber radio to playback the particular playlist.
Patent CA-2213689-A1 (CA)
Title: Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
Inventor: TUNG MING S
IPC: A61K33/00
Filed: 1995-02-24
Abstract: This invention involves methods and compositions for preparation of unstable carbonated calcium phosphate solutions, which are supersaturated with respect to calcium phosphate solids and carbon dioxide and the use of such solutions for the treatment of dental tissue and hyposalivation. Specifically the methods include mixing a stable alkaline carbonated solution containing carbonate with a stable acidic calcium solution, either or both solutions also containing phosphate to create an unstable carbonated solution with respect to calcium phosphate and carbon dioxide. Also, the methods include adding aqueous solution to the solids containing calcium salts, phosphate salts and carbonate salts to create an unstable carbonated solution supersaturated with respect to calcium phosphate solids and carbon dioxide. The methods further include using alkaline solutions to remove the acidic residue from dental tissue and maintain cariostatic conditions.
Patent CA-2215183-A1 (CA)
Title: Non-interruptible tap and method
Inventor: DALE JAMES L
IPC: H01R24/52
Filed: 1996-03-13
Abstract: A method and system for distributing multimedia signals to a subscriber (14) from a headend unit (12). The multimedia signals are transmitted on a network media as an RF signal. The RF signal is fed to an input terminal (50) of a tap (20) which has an RF circuit (58) that splits the RF signal and distributes to an output terminal (52). The RF circuit (58) splits the RF signals, and feeds the split signal to a plurality of connectors (30-36) on the tap's front panel (70). The RF signals on the output terminal (52) are fed downstream to a plurality of subscribers (14). A switch (42) is placed in the tap such that when the RF circuit (58) is removed for repair, maintenance or service, an electrical connection is maintained between the input (50) and output (52) terminal to prevent a disconnection of service downstream.
Patent CA-2215234-A1 (CA)
Title: Composition containing amlodipine, or its salt and an ace inhibitor
Inventor: KRASKA ALLEN R
IPC: A61K31/40
Filed: 1996-02-26
Abstract: Pharmaceutical compositions comprising (1) amlodipine, a pharmaceutically acceptable salt of amlodipine, or felodipine; (2) an ACE inhibitor, and, optionally, (3) a diuretic; and/or (4) digoxin. Use of the compositions result in improved morbidity and/or mortality for the treatment of congestive heart failure. Also, methods of treating congestive heart failure in a mammal, especially a human, by co-administration of (1) amlodipine, a pharmaceutically acceptable salt of amlodipine, or felodipine; (2) an ACE inhibitor, and optionally (3) a diuretic and/or (4) digoxin.
Patent CA-2215520-A1 (CA)
Title: Chlamydia vaccines
Inventor: SLAOUI MONCEF MOHAMED
IPC: A61K39/00
Filed: 1996-04-01
Abstract: A novel vaccine is presented for the prevention of Chlamydia infections utilising the outer membrane protein and two immunostimulants, 3D-MPL and QS21.
Patent CA-2216099-A1 (CA)
Title: Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
Inventor: GRABER DAVID R
IPC: C07D409/12
Filed: 1996-05-03
Abstract: The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula (I) and pyrimidine-thioalkyl and alkylethers of Formula (IA), namely the compounds of Formula (I) whew R4 is selected from the group consisitng of -H or-NR15R16 where R15 is -H and R16 is -H, C1-C6 alkyl, NH2 or R15 and R16 taken together with the -N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and R6 is selected from the group consisting of -H, or halo (preferably -Cl); with the overall proviso that R4 and R6 are not both -H. The compounds of Formula (IA) are useful in the treatment of individuals who are HIV positive being inhibitors of viral reverse transcriptase.
Patent CA-2216321-A1 (CA)
Title: Porous ceramics provided with amorphous pore surfaces and method for treating drain water and waste liquid by the use of same
Inventor: KUMAOKA SHUN ICHI
IPC: B01D39/20
Filed: 1997-09-19
Abstract: This invention relates to a method for treating various kinds of drain water and waste liquid which treatment now becomes a problem, for example, drain water and waste liquid containing hardly removable phosphorus and nitrogen, waste liquid containing organochlorine compounds such as tetrachloroethylene, etc., excretive drain water from a piggery containing organonitrogen compounds at a high level, waste liquid containing heavy metals such as lead, hexavalent chromium, cadmium and the like, drain water from dairy product plants, fishery processing plants, slaughterhouses, etc. which contains water soluble protein at a high level, drain water from pulp plants, photo developing waste liquid, car wash drain water containing a mixture of car polishing wax and detergent and the like by the use of porous ceramics provided with amorphous pore surfaces. Porous ceramics provided with amorphous pore surfaces is prepared by mixing clay, a pore forming material and water, molding into an arbitrary shape followed by drying, heating up an molded article thus dried, heating up an article temperature from normal temperature to 600 to 800 °C over atime period of 5 to 15 hours, maintaining this temperature for 3 to 7 hours and then calcinating at 1,200 to 1,500 °C.
Patent CA-2218593-A1 (CA)
Title: Method and system for automatic persistence of controls in a windowing environment
Inventor: ANDREW FELIX GTI
IPC: G06F3/0484
Filed: 1997-10-17
Abstract: A computer system for persistently storing information entered by a user into an edit control of a property page. In a preferred embodiment, the computer system has a registry for storage of information identified by a key. An application program has a resource file that contains a definition of controls for the property page. The controls include the edit control designated as editable by the user and a buddy control that is adjacent to the edit control, that is designated as not visible, and that has text which specifies a key within the registry. The computer system displays the property page by detecting that the buddy control is adjacent to the edit control and is designated as not visible, by retrieving the text for the buddy control, by retrieving information from the registry using the key specified by the retrieved text, and by initializing the edit control to the retrieved information. The computer system also allows a user to modify the information of the edit control and then stores the modified information of the edit control in the registry using the key specified by the retrieved text to effect persistent storage of the information for the edit control in the registry.
Patent CA-2220092-A1 (CA)
Title: A method of loading and treatment of hydrocarbons
Inventor: BREIVIK KARE
IPC: B63B21/50
Filed: 1996-05-14
Abstract: A method of loading and treatment of a gaseous or liquid hydrocarbon mixture produced on an offshore production platform, a production vessel or a well installation when producing oil and gas from a reservoir, wherein the mixture is supplied to a gas treatment vessel (12) via a buoy loading system comprising a buoy (14) of the STL/STP  type, and is treated on board the vessel (12) for producing liquefied natural gas (LNG) or an LPG mixture stored in tanks on the vessel.  Simultaneously with the supply of the hydrocarbon mixture, oil is also supplied to the vessel (12) via the same buoy (14), the buoy including a multi-course STP connector, the oil being transferred directly from the STP connector via a pipeline (23) and an unloading means (25) on the vessel (12) to a tanker (13) for storage and transport of the supplied oil.
Patent CA-2224028-A1 (CA)
Title: Positioning clamp and method of making thereof
Inventor: ALLERT KURT
IPC: F16B7/14
Filed: 1997-12-08
Abstract: The invention relates a positioning clamp with a ring-shaped base body and at least one radial clamping means associated with the base body. The base body (2) is formed as a deep-drawing part (31) and provided with a pocket (8) which is formed concurrently during deep-drawing, for at least partially receiving the radial clamping means (9). In addition, a method for making a positioning clamp is described.
Patent CA-2225997-A1 (CA)
Inventor: RODLAND KARIN D
IPC: C12Q1/6897
Filed: 1996-07-03
Abstract: In vitro assays which respond to signal pathway modulating compounds in transformed cells are described. By measuring the effect of candidate drugs on specific kinase targets, successful candidates can be screened. Tumor biopsies can be assayed for susceptibility to treatment with a particular drug using similar assays. The VL30 controlled expression of a reporter gene can also be used in screening assays for both inhibitors and stimulators of cell proliferation.
Patent CA-2228140-A1 (CA)
Title: Process for preparing hydrocarbons
Inventor: LEE KYO WAN
IPC: B01J23/78
Filed: 1995-10-27
Abstract: This invention relates to a process for preparing hydrocarbons, in particular hydrogenation of carbon dioxide over Fe-K/Al2O3 catalyst, which is reduced in hydrogen and activated in the mixture of carbon dioxide and hydrogen.
Patent CA-2228281-A1 (CA)
Title: Use of l-carnitine and acyl l-carnitines for lowering ceramide levels
Inventor: MORETTI SONIA
IPC: A61P27/00
Filed: 1996-07-19
Abstract: The therapeutic use of basic amino acids, acylated basic amino acids and their pharmacologically acceptable salts is disclosed for the preparation of a medicament for the prophylaxis of illnesses or the therapeutic treatment of cellular disorders accompanied by high levels of ceramide.
Patent CA-2229287-A1 (CA)
Inventor: GERSHENGORN MARVIN C
IPC: A61K48/00
Filed: 1996-08-12
Abstract: The present invention is directed to an in vivo cell transformed with DNA encoding a cell signalling receptor not endogenous to the cell. The cell signalling receptor is capable of activating a signal transduction pathway endogenous to the cell, and the cell signalling receptor can be controllably activated thereby controllably activating the signal transduction pathway so as to regulate a cell function controlled by the signal transduction pathway. The invention also provides a method of ectopically expressing a nonendogenous receptor in a cell, and a method of regulating a cell function in vivo. The method of regulating a cell function comprises transforming a cell with DNA encoding a cell signalling receptor not endogenous to the cell, as above, and controllably exposing the cell to an extracellular molecule capable of activating the foreign cell signalling receptor. Activation of the cell signalling receptor activates the endogenous signal transduction pathway so as to regulate a cell function controlled by the endogenous signal transduction pathway.
Patent CA-2235128-A1 (CA)
Title: Transistor-based apparatus and method for molecular detection and field enhancement
Inventor: SHIEH CHAN-LONG
IPC: C12Q1/68
Filed: 1997-08-07
Abstract: Binding of a molecule (24) to a molecular receptor (22) is sensed using a transistor (10) having a gate (14) located at a binding site. The channel (20) conductance of the transistor (10) is modified by a charge associated with the molecule (24) when the molecule (24) binds with the molecular receptor (22). A  modified electrical characteristic of the transistor (10) which results is sensed to sense the binding event. Electric field enhancement is provided by applying a voltage to the gate (14). A second sensing transistor can be coupled to the sensing transistor to form a differential pair. The differential pair allows for enhancing and sensing of differential binding events.
Patent CA-2235142-A1 (CA)
Title: Vacuum hold-down for folder/gluers and process
Inventor: ROBERTS JOHN T
IPC: B31B50/04
Filed: 1996-10-16
Abstract: The folder/gluer has lip seals (118) associated with each side plate (111) of the conveyor housing (110). These lip seals are slightly lower than the top surface of the feed conveyor belts (120). When the vacuum is applied to the vacuum holes (175), these lip seals do not allow the vacuum acting on the article sides to be bled off to the atmosphere. This results in conveyance far superior to anything known to date.
Patent CA-2235531-A1 (CA)
Title: Process for preparing cellulosic composites
Inventor: ZOMERS FRANCISCUS HILLEBRAND A
IPC: B27N1/00
Filed: 1998-04-22
Abstract: A process for the preparation of cellulosic composites from divided cellulosic fibrous material, which process comprises a hydrothermolytic treatment of the divided cellulosic fibrous material, carried out at a temperature in the range of 160 to 200°C, using water as softening agent, a drying or a drying and a curing step and a step in which dried or dried and cured particles of treated mate-rial are contacted with an adhesive, subsequently curing the adhesive-laden particles at increased temperature and pressure under formation of the desired composite.
Patent CA-2237400-A1 (CA)
Title: Procedes de traitement de troubles dans des epitheliums sensoriels non visuels
Inventor: CORWIN JEFFREY
IPC: A61K31/70
Filed: 1996-11-12
Abstract: D'une manière générale, la présente invention concerne des procédés permettant de promouvoir la fonction de cellules de l'oreille interne en utilisant des neurégulines. Un aspect nouveau de l'invention concerne l'emploi de neurégulines comme facteurs de croissance, pour promouvoir la fonction de cellules épithéliales sensorielles non visuelles. Le traitement de ces cellules pour obtenir ces effets peut être effectué en mettant lesdites cellules en contact avec un polypeptide qui figure dans la description. Les traitements peuvent être appliqués pour ralentir ou arrêter la perte nette de cellules ou pour accroître la quantité ou la qualité du tissu épithélial sensoriel non visuel qui existe chez le vertébré considéré.
Patent CA-2238856-A1 (CA)
Inventor: FU DAOTIAN
IPC: G01N30/46
Filed: 1996-11-27
Abstract: The present invention is directed to a method of detecting reducing carbohydrates in a complex biological sample. The sample is filtered, contacted with an anion exchange resin, derivatized with a 3-alkyl-5-pyrazolinone derivative, purified by liquid-liquid extraction and separated and detected by HPLC. The method can be used to monitor either various disease states or response to oligosaccharide therapy.
Patent CA-2240605-A1 (CA)
Title: Systeme electrolytique pour piles au lithium, utilisation de ce systeme et methode pour accroitre la securite des piles au lithium
Inventor: APPEL WOLFGANG
IPC: H01M10/0569
Filed: 1998-06-12
Abstract: Des systèmes d'électrolytes destinés aux piles au lithium plus sûrs renferment au moins un sel de lithium conducteur et au moins un fluide électrolytique et, selon l'invention, se définissent par une teneur efficace en au moins un carbamate partiellement fluoré de formule générale (I)  , où R1 et R2, qui peuvent être identiques ou différents, sont, indépendamment l'un de l'autre, un alkyle linéaire en C1 à C6, un alkyle ramifié en C3 à C6, un cycloalkyle en C3 à C7, ou R1 et R2, directement ou par l'intermédiaire d'un ou plusieurs atome(s) d'azote ou d'oxygène, sont liés pour former un cycle comptant 3 à 7 atomes, les atomes d'azote présents dans le cycle étant saturés avec un alkyle en C1 à C3, et les atomes de carbone du cycle pouvant eux aussi porter un alkyle en C1 à C3, un ou plusieurs atome(s) d'hydrogène des radicaux R1 et R2 pouvant en outre être remplacé(s) par un ou des atome(s) de fluor; R3 est un alkyle linéaire partiellement fluoré ou perfluoré comptant 1 à 6 atomes de carbone, est un alkyle ramifié partiellement fluoré ou perfluoré comptant 3 à 6 atomes de carbone, ou est un cycloalkyle partiellemen fluoré comptant 3 à 7 atomes de carbone, pouvant ou non porter un ou plusieurs substituant(s) alkyle en C1 à C6.
Patent CA-2246366-A1 (CA)
Inventor: BEEMILLER GERALD V
IPC: A47D9/02
Filed: 1997-02-06
Abstract: An infant environmental transition system (102, 202) provides an infant with controlled simulated movements encountered by an infant in an intrauterine environment. The cradle includes a suspension system having a plurality of flexures (106, 206, 207) coupled between a base plate (112, 212) and a moving bed platform (104, 204). A camshaft assembly (230) includes a groove (235) that engages a linear follower (218) connected to the moving bed platform (20) so that the follower (218) moves along the groove (235) while the camshaft assembly (230) rotates to move the linear follower (218), and thereby reciprocate the moving bed platform (204) in the longitudinal direction of the cradle. The camshaft assembly (230) also includes an eccentric cam (236) coupled to a rocker (242) that is coupled to one of the flexure's pivots to angularly displace the moving bed platform (204) supported on the flexures (206, 207), and thereby to simulate the intrauterine environment as the composite reciprocating and rotational movements of the moving bed platform.
Patent CA-2253281-A1 (CA)
Inventor: LILJA LAUNO
IPC: C22B3/02
Filed: 1997-04-29
Abstract: The invention relates to a method for recirculating the heavier solution from the separation part of liquid-liquid extraction to the mixing unit of the same extraction step, so that part of the recirculated solution is returned to the mixing unit from the overflow of the discharge end of the separation part. An essential feature of the invention is that the major part of the heavier solution recirculated into the mixing unit is obtained from the separation part proper, along the whole width thereof. The invention also relates to an apparatus based on said method, in which apparatus, in the bottom part of the settler (6) there is located a heavier solution collecting channel (13) extending over the whole width of the settler and being provided with suction pipes (15) which are oriented in an inclined fashion towards the solution to be collected from the channel.
Patent CA-2254474-A1 (CA)
Title: Modular imaging/treatment catheter assembly and method
Inventor: BAKER BRUCE A
IPC: A61F2/958
Filed: 1998-11-24
Abstract: Catheter assembly and method in which an imaging transducer is positioned proximally of a treatment device at the distal end of a catheter. Unrestricted flow between a fluid lumen in the catheter and the treatment device is provided by an annular passageway formed between the walls of a marker tube which extends through the transducer and a guide wire tube which passes through the marker tube, and by a plenum chamber which is formed between the distal end of the catheter and the proximal end of the marker tube in communication with the fluid lumen and the flow passageway. The catheter, the treatment device, and the transducer are all constructed as individual modular units which can be assembled together as desired to form the assembly.
Patent CA-2255277-A1 (CA)
Title: Solid battery
Inventor: KONO MICHIYUKI
IPC: H01M10/05
Filed: 1998-12-03
Abstract: A solid battery consisting of a positive electrode, a negative electrode and a separator disposed between the positive electrode and negative electrode wherein at least one of the positive electrode, the negative electrode and the separator comprises a solid electrolyte obtained by dissolving a tetrafunctional polymer compound and an electrolyte salt in a solvent and crosslinking the solution by the irradiation of an actinic radiation and/or by heating, which solid electrolyte comprises a tetrafunctional terminal acryloyl-modified alkylene oxide polymer having a polymer chain represented by following formula (I) as the tetrafunctional polymer compound, and the solvent at a ratio of from 220 to 1,900% by weight to the tetrafunctional polymer compound:      wherein R is a residue of an active hydrogen compound selected from the group consisting of diglycerol, pentaerythritol, methylglucoside and ethylenediamine, R1 and R2 each represents a hydrogen atom or a lower alkyl group; R3 represents a hydrogen atom or a methyl group; m and n each represents 0 or an integer of at least 1; in one high-molecular chain, m + n >= 35.        The solid battery has a high performance and a high-energy density, prevents the occurrence of liquid leakage and gas spouting, and has an excellent mechanical strength.